MYCN and neuroblastoma: In addition to MYCN as described above, a plethora of segmental chromosome alterations (SCAs) are associated with poor prognosis in NB, notably deletion of 1p and 11q, and gain of 17q; most high-risk tumours carry at least one such alteration.